Annual report pursuant to Section 13 and 15(d)

Stockholders' Deficit

Stockholders' Deficit
12 Months Ended
Jun. 30, 2018
Equity [Abstract]  
Stockholders' Deficit

11. Stockholders’ Deficit On October 16, 2013, the Nightfood, Inc. became a wholly-owned subsidiary of Nightfood Holdings, Inc. Accordingly, the stockholders’ equity has been revised to reflect the share exchange on a retroactive basis.


    The Company is authorized to issue One Hundred Million (200,000,000) shares of $0.001 par value per share Common Stock. Holders of Common Stock are each entitled to cast one vote for each Share held of record on all matters presented to shareholders. Cumulative voting is not allowed; hence, the holders of a majority of the outstanding Common Stock can elect all directors. Holders of Common Stock are entitled to receive such dividends as may be declared by the Board of Directors out of funds legally available therefore and, in the event of liquidation, to share pro-rata in any distribution of the Company’s assets after payment of liabilities. The Board of Directors is not obligated to declare a dividend and it is not anticipated that dividends will be paid unless and until the Company is profitable. Holders of Common Stock do not have pre-emptive rights to subscribe to additional shares if issued by the Company. There are no conversion, redemption, sinking fund or similar provisions regarding the Common Stock. All of the outstanding Shares of Common Stock are fully paid and non-assessable and all of the Shares of Common Stock offered thereby will be, upon issuance, fully paid and non-assessable. Holders of Shares of Common Stock will have full rights to vote on all matters brought before shareholders for their approval, subject to preferential rights of holders of any series of Preferred Stock. Holders of the Common Stock will be entitled to receive dividends, if and as declared by the Board of Directors, out of funds legally available, and share pro-rata in any distributions to holders of Common Stock upon liquidation. The holders of Common Stock will have no conversion, pre-emptive or other subscription rights. Upon any liquidation, dissolution or winding-up of the Company, assets, after the payment of debts and liabilities and any liquidation preferences of, and unpaid dividends on, any class of preferred stock then outstanding, will be distributed pro-rata to the holders of the common stock. The holders of the common stock have no right to require the Company to redeem or purchase their shares. Holders of shares of common stock do not have cumulative voting rights, which means that the holders of more than 50% of the outstanding shares, voting for the election of directors, can elect all of the directors to be elected, if they so choose, and, in that event, the holders of the remaining shares will not be able to elect any of our directors.


    The Company has 42,608,329 and 29,724,432 shares of its $0.001 par value common stock issued and outstanding as of June 30, 2018 and 2017 respectively.
    During the year ended June 30, 2018:


    the Company sold 464,085 shares of common stock for cash proceeds of $60,000,
    and issued 2,658,455 shares of common stock for services with a fair value of $554,353,
    and issued 270,382 shares of common stock in consideration of interest payments with a fair value of $20,487,
    and issued  9,490,975 shares of common stock as consideration for convertible debt with a fair value of $574,618.


    The Company has never declared dividends.





The following is a summary of the Company’s outstanding common stock purchase warrants.  The 500,000 warrants shown below at an exercise price of $.15 have not   yet vested.  These warrants were issued as compensation for a four-year advisory agreement.  Should the advisor complete the entire term of the engagement, 150,000 warrants will vest on July 24, 2018, another 150,000 on July 24, 2019, another 150,000 on July 24, 2020, and the remaining 50,000 on July 24, 2021.


The aggregate intrinsic value of the warrants as of June 30, 2018 is $190,475


        Outstanding at                 Outstanding  
  Exercise Price     June 30,
    Issued in
    Expired     June 30,
  $ 0.15       -       500,000       -       500,000  
  $ 0.20       -       105,000       -       105,000  
  $ 0.30       -       500,000       -       500,000  
  $ 0.75       300,000       -       -       300,000  
            300,000       1,105,000       -       1,405,000  


    The Company has never issued options.